Patterns of Rectal Cancer Radiotherapy Adopting Evidence-Based Medicine: An Analysis of the National Database from 2005 to 2016
- PMID: 29081217
- PMCID: PMC6056965
- DOI: 10.4143/crt.2017.459
Patterns of Rectal Cancer Radiotherapy Adopting Evidence-Based Medicine: An Analysis of the National Database from 2005 to 2016
Abstract
Purpose: Not many studies have evaluated the adoption and dissemination of evidence-based medicine in rectal cancer radiotherapy (RT). We aimed to analyze the differences by institutional characteristics and geography in adopting evidence-based care for rectal cancer RT and factors affecting the adoption in Korea.
Materials and methods: Korean National Health Insurance Service claims database was used. All rectal cancer patients treated with radical surgery and adjuvant RT at the same institution in 2005-2016 were included in this study. RT within 3 months before and after surgery was regarded as preoperative and postoperative RT, respectively.
Results: A total of 16,827 patients treated in 83 institutions were included in the analysis. The use of preoperative RT has substantially increased over time, from 40.6% in 2005 to 84.2% in 2016 all over the nation. The proportion of preoperative RT (54.8%) exceeded that of postoperative RT (45.2%) in 2006. However, a wide range of institutional and regional variation was observed. Compared to high-volume institutions, low-volume institutions showed late adoption and variable dissemination patterns of preoperative RT. Busan-Ulsan-Gyeongsangnam-do and Gangwon-do showed slower adoption and less use of preoperative RT than other region.
Conclusion: We demonstrated gradual and steady increase in adoption of preoperative RT in rectal cancer treatment nationally from 2005 to 2016. Institutional variations between high- and low-volume institutions were observed.
Keywords: Evidence-based medicine; Patterns of care; Preoperative radiotherapy; Rectal neoplasms.
Conflict of interest statement
Conflict of interest relevant to this article was not reported.
Figures


References
-
- Gastrointestinal Tumor Study Group Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312:1465–72. - PubMed
-
- Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al. Effective surgical adjuvant therapy for highrisk rectal carcinoma. N Engl J Med. 1991;324:709–15. - PubMed
-
- Fitzgerald TL, Biswas T, O'Brien K, Zervos EE, Wong JH. Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice. World J Surg. 2013;37:639–45. - PubMed
-
- Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40. - PubMed
-
- Koperny M, Lesniak W, Jankowski M, Bala M. The Cochrane collaboration: the role in the evolution of evidence-based medicine and development of cooperation in Poland. Przegl Epidemiol. 2016;70:508–20. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources